Assuming multiple is required, the following results were found.

  • Multiple sclerosis: Helping cells to help themselves

    Date: Source: Charité - Universitätsmedizin Berlin Summary: Diseases such as multiple sclerosis are characterized by damage to the 'myelin sheath', a protective covering wrapped around nerve cells akin to insulation around an electrical wire....

    https://mschristian.org/index.php/articles/2-uncategorised/5402-multiple-sclerosis-helping-cells-to-help-themselves
  • 2025 Projections: Multiple Sclerosis Industry Market Report by Type, Application and Regional Outlook - AlgosOnline

    MarketStudyReport.com Adds New Report about Global Multiple Sclerosis Industry Market to its database. This research covers the market landscape and its growth prospects over the coming years. The research study on the Multiple Sclerosis Industry...

    https://mschristian.org/index.php/articles/2-uncategorised/10913-2025-projections-multiple-sclerosis-industry-market-report-by-type-application-and-regional-outlook-algosonline
  • Link between gut flora and multiple sclerosis discovered

    Date: Source: University of Zurich Summary: In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than...

    https://mschristian.org/index.php/articles/2-uncategorised/8746-link-between-gut-flora-and-multiple-sclerosis-discovered
  • 2025 Projections: Multiple Sclerosis Industry Market Report by Type, Application and Regional Outlook - AlgosOnline

    MarketStudyReport.com Adds New Report about Global Multiple Sclerosis Industry Market to its database. This research covers the market landscape and its growth prospects over the coming years. The research study on the Multiple Sclerosis Industry...

    https://mschristian.org/index.php/component/easyblog/2025-projections-multiple-sclerosis-industry-market-report-by-type-application-and-regional-outlook-algosonline?Itemid=101
  • Multiple Sclerosis Drugs Market 2019| Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2026 | Research Industry US - News Obtain

    Global Multiple Sclerosis Drugs Market presents insights on the current and future industry trends, enabling the readers to identify the product and services, hence driving the revenue growth and profitability. The research report provides a detailed...

    https://mschristian.org/index.php/component/easyblog/multiple-sclerosis-drugs-market-2019-recent-trends-in-depth-analysis-market-size-research-report-forecast-up-to-2026-research-industry-us-news-obtain?Itemid=341
  • Brain's lymphatic vessels as new avenue to treat multiple sclerosis

    Lymphatic vessels that clean the brain of harmful material play a crucial role in the development and progression of multiple sclerosis, new research from the University of Virginia School of Medicine suggests. The vessels appear to carry previously...

    https://mschristian.org/index.php/component/easyblog/brain-s-lymphatic-vessels-as-new-avenue-to-treat-multiple-sclerosis?Itemid=341
  • Link between gut flora and multiple sclerosis discovered

    Date:Source:University of ZurichSummary:In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than...

    https://mschristian.org/index.php/component/easyblog/link-between-gut-flora-and-multiple-sclerosis-discovered?Itemid=341
  • Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosis

    Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the body's immune system to reduce disease symptoms and disability. They do not induce, however, repair of...

    https://mschristian.org/index.php/articles/2-uncategorised/9003-chemical-compound-produces-beneficial-inflammation-remyelination-that-could-help-treat-multiple-sclerosis
  • Brain's lymphatic vessels as new avenue to treat multiple sclerosis

    Lymphatic vessels that clean the brain of harmful material play a crucial role in the development and progression of multiple sclerosis, new research from the University of Virginia School of Medicine suggests. The vessels appear to carry previously...

    https://mschristian.org/index.php/articles/2-uncategorised/8747-brain-s-lymphatic-vessels-as-new-avenue-to-treat-multiple-sclerosis
  • Multiple sclerosis: Perilous ruptures

    Date: Source: Ludwig-Maximilians-Universität München Summary: The permanent neurological deficits of multiple sclerosis patients largely depend on the extent of degeneration of long nerve fibers. The latter is initiated by ruptures in the cell membrane...

    https://mschristian.org/index.php/articles/2-uncategorised/5481-multiple-sclerosis-perilous-ruptures
  • B cells among factors leading to brain lesions in multiple sclerosis

    Date: Source: University of Zurich Summary: A team of researchers has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain. B cells, a different type of immune cell, also play a role. These...

    https://mschristian.org/index.php/articles/2-uncategorised/4422-b-cells-among-factors-leading-to-brain-lesions-in-multiple-sclerosis
  • First clues to the causes of multiple sclerosis

    Multiple sclerosis, which affects 1 in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties with speech. There is...

    https://mschristian.org/index.php/articles/2-uncategorised/4099-first-clues-to-the-causes-of-multiple-sclerosis
  • First clues to the causes of multiple sclerosis

    Multiple sclerosis, which affects 1 in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties with speech. There is...

    https://mschristian.org/index.php/component/easyblog/first-clues-to-the-causes-of-multiple-sclerosis?Itemid=341
  • What to know about secondary progressive multiple sclerosis (SPMS)

    Table of contents Secondary progressive multiple sclerosis is a later stage of multiple sclerosis. Instead of having symptom relapses and remissions, a person's symptoms steadily get worse over time. Most people, but not everyone, with...

    https://mschristian.org/index.php/component/easyblog/what-to-know-about-secondary-progressive-multiple-sclerosis-spms-1?Itemid=341
  • Coronavirus and MS Reporting Database Announced by Consortium of Multiple Sclerosis Centers & National Multiple Sclerosis Society

    Coronavirus and MS Reporting Database Announced by Consortium of Multiple Sclerosis Centers & National Multiple Sclerosis Society Click HERE to Register for the MS Beacon Newsletter COVID-19 – WHAT HAVE WE LEARNED SO FAR? Authors: Katrina Mountfort,...

    https://mschristian.org/index.php/articles/2-uncategorised/10599-coronavirus-and-ms-reporting-database-announced-by-consortium-of-multiple-sclerosis-centers-national-multiple-sclerosis-society
  • Conceptual framework to study role of exercise in multiple sclerosis

    a conceptual framework for examining the relationship between exercise and adaptive neuroplasticity in the population with multiple sclerosis (MS). FULL STORY Researchers have proposed a conceptual framework for examining the relationship between...

    https://mschristian.org/index.php/articles/2-uncategorised/4542-conceptual-framework-to-study-role-of-exercise-in-multiple-sclerosis
  • Aubagio (teriflunomide)

    doctor right away. What is Aubagio? Aubagio is a brand-name prescription medication. It's used to treat relapsing forms of multiple sclerosis (MS) in adults. MS is an illness in which your immune system attacks your central nervous system. Aubagio...

    https://mschristian.org/index.php/component/easyblog/aubagio-teriflunomide?Itemid=341
  • The MS Coalition invites you to join us for the 2019 Multiple Sclerosis Summit on Saturday, November 9, 2019 at the Westin Lombard, Illinois

    2019 Multiple Sclerosis Summit Saturday, November 9, 2019 – Lombard, Illinois The MS Coalition invites you to join us for the 2019 Multiple Sclerosis Summit on Saturday, November 9, 2019 at the Westin Lombard located at 70 Yorktown Center in Lombard,...

    https://mschristian.org/index.php/articles/2-uncategorised/8792-the-ms-coalition-invites-you-to-join-us-for-the-2019-multiple-sclerosis-summit-on-saturday-november-9-2019-at-the-westin-lombard-illinois
  • Genomic map implicates broad immune cell involvement in multiple sclerosis

    The International Multiple Sclerosis Genetic Consortium (IMSGC) reports the results of its latest study, "Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility," in the journal Science today: the highly...

    https://mschristian.org/index.php/articles/2-uncategorised/8755-genomic-map-implicates-broad-immune-cell-involvement-in-multiple-sclerosis
  • Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosis

    Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the body's immune system to reduce disease symptoms and disability. They do not induce, however, repair of...

    https://mschristian.org/index.php/component/easyblog/chemical-compound-produces-beneficial-inflammation-remyelination-that-could-help-treat-multiple-sclerosis?Itemid=341

Results 21 - 40 of 874